GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Dara Aisner, Pathologist at the University of Colorado, defines the field of pathology and molecular marker testing for cancer.

Direct download: GRACEcast-127_CA-101-Video_Aisner_on_Molecular_Pathology.m4v
Category:Cancer-101-Video -- posted at: 9:20pm PDT

Dr. Dara Aisner, Pathologist at the University of Colorado, defines the field of pathology and molecular marker testing for cancer.

Direct download: GRACEcast-127_CA-101-Audio_Aisner_on_Molecular_Pathology.mp3
Category:Cancer-101-Audio -- posted at: 9:19pm PDT

Dr. H. Jack West reviews the TOPICAL study of Tarceva vs. placebo for marginal and poor PS patients with advanced NSCLC, which showed a clearly superior outcome with Tarceva in patients who developed a rash vs. those who don't.

Direct download: GRACEcastUC-005_Lung-Video_Rash_a_Factor_with_EGFR.m4v
Category:Lung-Cancer-Video -- posted at: 6:18pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews the rationale and feasibility of using focal radiation in the setting of metastatic lung cancer.

Direct download: GRACEcast-126_Rad-Video_Refining_Radiation_Therapy_6.m4v
Category:Radiation-Video -- posted at: 4:48pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews the rationale and feasibility of using focal radiation in the setting of metastatic lung cancer.

Direct download: GRACEcast-126_Rad-Audio_Refining_Radiation_Therapy_6.mp3
Category:Radiation-Audio -- posted at: 4:47pm PDT

Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  reviews the rationale for giving chemotherapy to patients with NSCLC even when it appears that the cancer is limited to the chest.

Direct download: GRACEcastUC-004_Lung-Video_Why_Chemptherapy_for_Most.m4v
Category:Lung-Cancer-Video -- posted at: 3:22pm PDT

Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  discusses recent developments around pricing and value for Zaltrap (ziv-aflibercept) triggered by a New York Times op-ed piece by MSKCC physicians.


Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  reviews the general principles of treating locally advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcastUC-002_Lung-Video_How_Should_We_Treat_NSCLC.m4v
Category:Lung-Cancer-Video -- posted at: 12:57pm PDT

Dr. H. Jack West describes the new format of presenting cancer information in brief, more casual video-based format.

Direct download: GRACEcastUC-001_CA-101-Video_Intro_to_GRACEcasts_Uncut.mp4
Category:Cancer-101-Video -- posted at: 10:32pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes new technologies that are improving the accuracy and safety of radiation for stage non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-125_Rad-Video_Refining_Radiation_Therapy_5.m4v
Category:Radiation-Video -- posted at: 9:46pm PDT